Hospital center Henri Mondor in Aurillac
- Address
- 50 Avenue De La Republique, 15002 Aurillac, France
Hospital Center Henri Mondor - Respiratory Medicine Research
Hospital Center Henri Mondor in Aurillac is actively engaged in clinical research focusing on respiratory medicine and chronic pulmonary conditions. The center specializes in evaluating advanced therapeutic interventions for patients with severe respiratory disease, with particular emphasis on optimizing treatment strategies through comparative effectiveness studies.
- Chronic Obstructive Pulmonary Disease (COPD) management and treatment optimization
- Cardiopulmonary outcomes assessment in respiratory disorders
- Advanced inhalation therapy combinations including bronchodilators and corticosteroids
The research team at Henri Mondor evaluates innovative triple therapy combinations including budesonide, glycopyrronium, and formoterol fumarate delivered via metered-dose inhalers. Their work focuses on assessing severe cardiopulmonary outcomes and comparing the efficacy of combination therapies versus dual bronchodilator approaches, contributing valuable evidence to guide clinical practice in COPD management and improve quality of life for patients with chronic respiratory conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 10 therapeutic areas and 15 of 58 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 50 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 14 by active trials.
lock +13 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +5 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital center Henri Mondor in Aurillac
lock Showing 1 of 25 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized Controlled Trial Comparing Azathioprine and Methotrexate in Combination with Adalimumab for Endoscopic Response in Crohn's Disease Patients | Centre Hospitalier Universitaire Amiens Picardie | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 58 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluorouracil | 5 | Unknown | 2024-02-26 | 2026-05-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.